Author Correction: Mucosal vaccine-induced cross-reactive CD8 + T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

Baoling Ying,Tamarand L. Darling,Pritesh Desai,Chieh-Yu Liang,Igor P. Dmitriev,Nadia Soudani,Traci Bricker,Elena A. Kashentseva,Houda Harastani,Saravanan Raju,Meizi Liu,Aaron G. Schmidt,David T. Curiel,Adrianus C. M. Boon,Michael S. Diamond

DOI: https://doi.org/10.1038/s41590-024-01781-5

IF: 30.5

2024-02-16

Nature Immunology

Abstract:Nature Immunology - Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

immunology

What problem does this paper attempt to address?

According to the provided text content, this is a correction notice for a published paper in "Nature Immunology". The main content of the paper is a study on the protective effect of cross - reactive CD8+ T cells induced by mucosal vaccines against SARS - CoV - 2 XBB.1.5 respiratory tract infection. Specifically, the problem that this paper attempts to solve is:

**How can cross - reactive CD8+ T cells induced by mucosal vaccines provide protection against the SARS - CoV - 2 XBB.1.5 variant, especially protection against respiratory tract infection?**

The correction content mentioned in the original text only involves the problem of repeated "Naive" column images in Figure 5c and e. This error does not affect the scientific nature of the research results and the validity of the conclusions. Therefore, the core problem and research purpose of the paper have not changed.